Heart Failure Flashcards

1
Q

How can we define heart failure?

A

It is a state in which the heart isn’t able to provide sufficient cardiac output to match the metabolic demands of heart and other tissues. There are many different symptoms with different presentations with many DDX. It is therefore important to follow a certain reasoning when there is suspicion of HF.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are some common signs and symptoms of heart failure?

A

Shortness of breath DDX with respiratory disease, memory problems worsening, waking up many times during the night DDX with renal issues, cough DDX with many respiratory diseases, swollen or tender abdomen, swelling of feet DDX peripheral vein issues.
None of these symptoms will guarantee HF diagnosis although may help with other gathered information to give diagnoses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are some congestive events caused by HF?

A

Impact on liver : stasis of blood, impairment of liver function will change levels of liver proteins as lower albumin, changes in ALT and AST, and alteration of coagulation factors.

Impact on intestine : intestinal edema, tenderness, congestion.

Impact on legs : peripheral edema of different entities.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are some abnormal perfusion events caused by HF?

A

Impact on brain : temporary hypo-perfusion.

Impact on kidneys : 25% of cardiac output goes to kidneys, if it decreases they will respond activating RAAS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are some compensatory mechanisms against HF?

A

Decreased blood flow to the kidney activates the RAAS to increase blood pressure and water reabsorption to increase blood volume. This is called vascular congestion which may turn into tissue congestion.

Sympathetic activation will increase HR to increase cardiac output since EF is decreasing.

These mechanism are only helpful at the beginning but are harmful long term.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why is EF important in HF?

A

If EF is decreased than it is a sure sign of HF. If it is not decreased it doesn’t mean there isn’t HF as the stroke volume could be decreased due to hypertrophy leading to a decreased CO.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How can we suspect HF?

A

We asses risk factors such as hypertension, lipid levels and coronary artery disease. Look out for signs and symptoms indicating possible HF. Analyze ECG for any abnormalities.

Check for BNP which is B type Natriuretic peptide. If normal unlikely HF if not it can strongly suggest HF.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the different causes of HF clustering them based on importance?

A

IHD : myocardial scarring after necrosis or fibrosis, myocardial stunning after prolonged ischemia, epicardial coronary artery disease, abnormal coronary micro circulation and endothelial dysfunction.

Toxic damage : recreational substance abuse such as cocaine and anabolic steroids, heavy metals like copper and lead, medications like transtuzumab and cetuximab, radiation.

Infiltration : related to malignancies, related to metabolic disorders like hemochromatosis or other systemic diseases like amyloidosis and sarcoidosis.

Metabolic changes : obesity, it is a direct cause of HF without reduced EF.

Abnormal loading conditions : hypertension, valvular defects, myocardium structural defects, constrictive pericarditis, severe anemia.

Arrhythmias such as tachyarrhythmias and bradyarrhythmias.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do myocytes adapt to increased stress? How is it related to HF?

A

Myocytes need to adapt to maintain sufficient CO during stress. To increase the EF concentric hypertrophy can occur, to combat volume overload eccentric hypertrophy can occur.
These compensatory mechanisms will eventually worsen HF.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the epidemiology of HF?

A

HF is a chronic progressive disease with same prognosis of lung cancer, it is a very severe condition and can cause sudden death despite sometimes being asymptomatic and worsening within few days. Prevalence: 1-3% in general population.
Mortality after an acute event after 5 years is 50%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Why are paroxysmal nocturnal dyspnea and orthopnea among the most important symptoms of HF?

A

Orthopnea is the sensation of breathlessness in the recumbent position, relieved by sitting or standing. Paroxysmal nocturnal dyspnea is the sensation of shortness of breath that awakens the patient, often after 1 or 2 hours of sleep.
This occurs because when laying down gravity is no longer working against venous flow therefore increase venous flow to the RV. In a normal heart because of the frank sterling mechanism the heart can manage by increasing stroke volume. In a person with heart failure, the left ventricle has an inadequate capacity to respond to increased arrival of blood from the pulmonary circulation leading to congestion. Which could in turn lead to interstitial trasudation or even alveolar trasudation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How can we examine the jugular venous pressure? Why is it helpful to diagnose HF?

A

Patient must be recumbent on his back at a 45 degree angle. Measure the vertical distance between the angle of louis (palpable anatomical feature formed from the manubriosternal junction) and the most cranial visible part of the external jugular vein in cm. Add that to 5 cm as that is the distance from the angle of Louis to the right atrium. This roughly gives us the pressure in cm of water, cmH2O. Should be between 4 and 8.
A high JVD indicates backed up blood in the vein, a common symptom of HF.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are some treatments for congestion?

A

Loop diuretics : they are the standard for treatment of congested patient. They are natriuretics, facilitating Na+ outflow and thereby reducing circulating volume and intravascular congestion. Aren’t very effective on tissue congestion.

Aquaretics : vasopressin antagonists, not standard treatment, they cause pure water excretion at the level fo the kidney. They are better to recall water from tissues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the pathophysiology of congestion?

A

Under normal condition the hydrostatic pressures (outward pressure) and oncotic pressures (inward pressure) in the capillaries are in equilibrium. During compensated HF hydrostatic pressures rise and oncotic pressures decrease. This causes fluid to build up in the interstitial space.

Hydrostatic pressures decreases because of right side heart failure for example increasing pressure in venous system.

Oncontic pressure decreases because liver function is decreasing for example. Proteinsthat are meant to bring fluid in aren’t enough.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the signs and symptoms of intravascular congestion? How is it diagnosed?

A

Clinical signs : Increased jugular venous pressure, orthopnea, 3rd heart sound, acute distention of ventricle, sign of impaired filling.

Biomarkers : NT-proBNP and hemoconcentration.

Techniques : Inferior vena cava ultrasonography to check diameter, jugular vein ultrasonography to check JV pulse, renal ultrasonography and implantable pressure sensors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the signs and symptoms of tissue congestion? How is it diagnosed?

A

Clinical signs : Pitting edema which leaves indentations in affected areas, excess fluid composed mainly of water. Rales (crackles) sounds especially at bases. Ascites.

Biomarkers : No standard ones are available.

Techniques : Chest X-ray, pulmonary ultrasound , thoracic CT scan : for DDX of lung abnormalities. Thoracic impedance analysis : impedance is the resistance to an electric current, changing when there is fluid in the lungs.

17
Q

How does the New York Heart Association classify heart failure based on symptoms?

A

Class I : no limitation in physical activity, ordinary activity does not cause fatigue, palpitation or dyspnea.

Class II : slight limitation of physical activity, comfortable at rest but ordinary activity results in fatigue, palpitation or dyspnea.

Class III : marked limitation of physical activity.

Class IV : unable to carry on any physical activity without discomfort. Symptoms present also at rest.

18
Q

How does the American College of Cardiology-American Heart Association classify different stages of heart failure based on damage?

A

Stage A : at risk for HF. No identified structural or functional abnormality, no signs or symptoms. Ex. Obese or diabetic patients.

Stage B : developed structural heart disease that is associated with the development of HF. No signs or symptoms. Ex. IHD, mitral regurgitation.

Stage C : symptomatic HF associated with structural heart disease.

Stage D : advanced structural heart disease and marked symptoms of HF at rest despite medical therapy.

19
Q

What are key features in clinical examination of patients with heart failure?

A

Appearance : neurological status, nutritional status, weight (obesity), skin color (pallor). e.g. skin color-> e.g. pallor-> sign of anemia: worsening of HF paient can be due to low Hb levels rather than heart problems.

Pulse : check for heart rate, rhythm, character. Do not only assess arterial pulse but also JV.

Blood pressure : systolic, diastolic, pulse pressure (differential pressure).

Fluid overload : JVP, peripheral edema (ankles and sacrum), hepatomegaly, ascites.

Chest physical examination : lungs—> respiratory rate, respiratory sounds (rales), pleural effusion (assessed through percussion).

Heart : apex displacement, heart sounds (gallop rhythm, third heart sound, murmurs suggesing valvular dysfuncion).

Risk factor evaluation.

20
Q

What is central to peripheral dissociation?

A

You measure the heart rate centrally and peripheral. There is a difference in the heart rates measured. This can be because of atrial fibrillation.

21
Q

What are some lab data involved in diagnostic assessment of heart failure?

A

BNP, Hb, liver enzymes and renal function like eGFR and creatinine, urea, electrolytes, TSH, urine test to check for proteinuria, glucose test for HbA1C and lipids, troponin levels.

22
Q

What do we look for in a chest X ray during diagnoses of HF?

A

In a normal chest X-ray we see lungs that are almost homogeneous in colour (darker where there’s air and lighter where there are soft issues and vessels). In a chest X ray of a patient with heart failure you can see a large heart, fuzzy everywhere, with pleural effusion, typical signs of pulmonary edema.

23
Q

What do we look for on an ECG in patients with heart failure?

A

We look for tachycardia, afib, aflutter, ventricular arrhythmias, signs of ischemia, BBB, AV block and anything that could indicate abnormality.

24
Q

What are the main causes of death in end stage HF patients?

A

1-Severe acute HF with severe untreatable congestion.
2-Ventricular fibrillation.

25
Q

What are some drugs used in HFrEF management?

A

ACE inhibitors, Angiotensin Receptor Neprilysin Inhibitors (ARNI), beta blockers, mineralocorticoid antagonist (MRA), SLGT-2 inhibitors like dapaglifozin, loop diuretics.
These are all class I (recommended).

26
Q

What are some names of ACEi, BB, MRA, ARNI and SLGT2i?

A

ACEi : most common is ramipril. Others include enalapril and lisinopril.
ARNI : sacubitril.
BB : bisoprolol is the most common, nebivolol.
MRA : eplerenone and spironolactone.
SLGT2i : dapaglifozin and empaglifozin.

27
Q

What is the H2FpEF score?

A

It is a score used to calculate the probability of a patient to develop HFpEF based on his/her clinical presentation.
H2 stand for Heavy, BMI>30 (2 points) and Hypertensive, 2 or more antihypertensive medicine (1 point).
F stands for afib (3 points).
P for pulmonary hypertension, pulmonary artery systolic pressure > 35 mmHg (1 point).
E for elder, age >60 (1 point).
F for filling pressure, Doppler echo E/e’ >9 (1 point).

The more points the higher the probability of developing HFpEF.

28
Q

What are the different phenotypes of HFpEF?

A

Cardiorenal HFpEF : mostly related to aging and chronic kidney disease.
Autoimmue inflammatory HFpEF : possibly related to irritable bowel disease, psoriasis and rheumatoid arthritis.
Cardiometabolic HFpEF : phenotype associated with lipid accumulation, maladaptive inflammatory processes, progressive fibrosis and multi organ failure.

29
Q

How are patients with HFmrEF managed?

A

First line treatment is diuretics for fluid retention and SLGT2i like dapaglifozin and empaglifozin. Second line is the addition of ACEi, ARNI, ARB, MRA and BB.

30
Q

Why is obesity such a risk for cardiovascular disease?

A

It is most due to the high level of inflammatory cytokines that are related to obesity. These can cause glucose intolerance, type II diabetes, endothelial dysfunction which increase chance of CVD. Obesity its self causes hypertension, dyslipidemia and obstructive sleep apnea.

31
Q

What are the different stages of HF that can be identified?

A
  1. Asymptomatic LV dysfunction : no symptoms but abnormal LV function.
  2. Compensated CHF : symptoms at this stage are related to exercise and acts as compensatory mechanisms ( higher sympathetic tone, increased HR, myocyte alteration).
  3. Decompensated CHF : symptoms at rest, can ameliorate with intervention.
  4. Refractory CHF : symptoms are not controlled, dyspnea at rest.
32
Q

How are the different symptoms of CHF classified and what class of drugs can be used?

A

Congestive symptoms : shortness of breath, waking up short of breath at night, chest pain, heart palpitations, fatigue when you’re active, swelling in your ankles, legs and abdomen, weight gain, need to urinate while resting at night.

Low output symptoms : low blood pressure, weak pulse, cool extremities, decreased urine output, altered mental status such as confusion, shortness of breath, arrhythmia and fatigue.

Inotropes : improve the low output symptoms but not able to address congestive symptoms.

Diuretics : decrease blood volume and venous pressure therefore improve congestive symptoms but not able to address low output symptoms.

Vasodilators : address the excess of preload and afterload therefore would act on both low output (reducing peripheral resistance) and congestive symptoms (improve in cardiac output and venous return).

33
Q

What are the guideline therapeutic regimen for HF?

A

ACE inhibitor or ARNI (AngII-R Nepr Inhib) + beta blockers + mineralocorticoid receptor antagonist.

In 2021 they added glifozins : dapagliflozin or empagliflozin, used in type 2 diabetic patients to get rid of excessive glucose, nowadays recommended even for non-diabetic patients.

34
Q

How to ACE inhibitors work?

A

ACE inhibtors work by blocking conversion of angiotensin I into angiotensin II which acts as a vasoconstrictor, activating aldosterone, vasopressin, and the sympathetic tone. ACE inhibitors are also blocking bradykinin degradation and this can explain some of the side effects related to the drug.

Hemodynamic effect include arteriovenous vasodilation, a decreased in BP, LVEDP, systemic vascular resistance. They cause in increase in cardiac output and exercise tolerance.

ACEi can also be involved in blocking the cardiac hypertrophy remodeling that is usually maladaptive in the long range, so targeting this mechanism could reduce HF progression.

It is indicated as treatment in all patients with clinical cardiac insufficiencies and patients with a LVEF < 40%.

Side effects include : hypotension, hyperkalemia, dry cough, renal insufficiency, upset digestive tract, cutaneous eruptions and proteinuria.

Ex. Captopril and enalapril.

35
Q

What are other drugs used for CHF?

A

Sacubitril (inhibitor of neprilysin) + valsartan (AR2 antagonist) showed better results than enalapril alone.

Beta blocker such as bisoprolol, carvediolol, metoprolol and nebivolol are ideal for patients with suspected adrenergic activation, arrhythmias, hypertension and angina.

SLGT2 inhibitors like dapaglifozin, empaglifozin and sotaglifozin are approved for HF as they show mechanism involving cardio protection.

Inotropes like digoxin (Na-K ATPase inhibitor) increase Ca in the heart leading to increased contractility.

36
Q

Management regimen for patients with HFpEF?

A

First line is diuretics, SLGT2i and treatment of CV and non-CV comorbodities.